Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty

American Journal of Cardiology

Volumn 77, Issue 8, 1996, Pages 649-652

  O'Keefe Jr , James H ^a   Stone, Gregg W ^a   McCallister Jr , Benjamin D ^a   Maddex, Cheryl ^a   Ligon, Robert ^a   Kacich, Ray L ^a   Kahn, Joel ^a   Cavero, Patricia G ^a   Hartzler, Geoffrey O ^a   McCallister, Ben D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PLACEBO; PROBUCOL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYALGIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0029949172     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)89325-3     Document Type: Article

References (7)

1. Walldius G, Erikson U, Olsson AG, Bergstrand L, Hadell K, Johansson J, Kaijser L, Lassvik C, Mölgaard J, Nilsson S, et al. The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol 1994;74:875-883.
2. O'Keefe JH, Lavie CJ, McCallister BD. Insights into the pathogenesis and prevention of coronary artery disease. Mayo Clin Proc 1995;70:69-79.
3. Eckardt H, Volker W, Bruning T, Faber V, Buddecke E. Lovastatin reduces myointimal proliferation after vascular surgery (abstr). Eur Heart J 1991;12(suppl):9.
4. Gellman J, Ezekowitz MD, Sarembock IJ, et al. Effect of lovastatin on intimal hyperplasia after balloon angioplasty: a study in an atherosclerotic hypercholesterolemic rabbit. J Am Coll Cardiol 1991;17:251-259.
5. Sahni R, Maniet AR, Voci G, Banka VS. Prevention of restenosis by lovastatin after successful coronary angioplasty. Am Heart J 1991;121:1600-1608.
6. Weintraub WS, Boccuzzi SJ, Klein JL, Kosinski AS, King SB, Ivanhoe R, Cedarholm JC, Stillabower ME, Talley JD, DeMaio SJ, O'Neill WW, Frazier JE, Cohen-Bernstein CL, Robbins DC, Brown CL, Alexander RW, and the Lovastatin Restenosis Trial Study Group. Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med 1994;331:1331-1337.
7. Weintraub WS, Boccuzzi SJ, Brown CL, Cohen CL, Hirsch LJ, King SB, Alexander RW, and the Lovastatin Restenosis Trial Study Group. Background and methods for lovastatin restenosis trial after percutaneous transluminal angioplasty. Am J Cardiol 1992;70:293-299.